Christopher Turner was appointed Chief Medical Officer of Nuvalent, Inc. on August 14, 2025.
1 report, 1 independent
Updated Aug 14
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Christopher Turner was appointed Chief Medical Officer of Nuvalent, Inc. on August 14, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Nuvalent, Inc. (United States)
company in Cambridge, United States
Nothing else this week.
-
Christopher Turner
researcher (ORCID 0000-0002-8091-1108)
Nothing else this week.
Coverage
Newest first; wire copies grouped- PR NewswireNuvalent to Present Pivotal Data from ARROS-1 Clinical Trial of Zidesamtinib for TKI Pre-treated Patients with Advanced ROS1-positive NSCLC at WCLC 2025 Presidential Symposium CAMBRIDGE, Mass., Aug.